Government Affairs The $8M-revenue Generic Pharmaceutical Association said that Vice President of Regulatory Sciences Gordon Johnston has resigned. Johnston had held the position—in which he was the primary industry spokesperson on science and regulatory matters—since 2003. He will continue as senior advisor for regulatory sciences. McCormack Sandin Lee Bush Brown Harris Smith “Gordon’s commitment and contributions to the generic pharmaceutical industry over the years cannot be overstated,” said Paul Bisaro, GPhA chair and CEO of Watson Pharmaceuticals, in a statement. “He has helped increase communication and… Read More